Details of Disease

General Information of Disease (ID: DISYPWD6)

• Disease Name: Serious infection
• Disease Class: 1H0Z: Unspecific infection
• Disease Hierarchy:
  DIS01GPL: Grass pollen hypersensitivity
  DISYPWD6: Serious infection
• ICD Code:
  ICD-11: ICD-11: 1H0Z
  ICD-10: ICD-10: A00-B99
  ICD-9: ICD-9: 001-139
  Expand ICD-9: 001,002,003,004,005,006,007,008,009,010,011,012,013,014,015,016,017,018,019,020,021,022,023,024,025,026,027,028,029,030,031,032,033,034,035,036,037,038,039,040,041,042,043,044,045,046,047,048,049,050,051,052,053,054,055,056,057,058,059,060,061,062,063,064,065,066,067,068,069,070,071,072,073,074,075,076,077,078,079,080,081,082,083,084,085,086,087,088,089,090,091,092,093,094,095,096,097,098,099,100,101,102,103,104,105,106,107,108,109,110,111,112,113,114,115,116,117,118,119,120,121,122,123,124,125,126,127,128,129,130,131,132,133,134,135,136,137,138,139

Drug-Interaction Atlas (DIA) of This Disease

This Disease is Treated as An Indication in 2 Clinical Trial Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
CAZ AVI	DMPG4OM	Phase 3	NA	[1]
SAR279356	DMEGNHZ	Phase 2	NA	[2]

Molecular Interaction Atlas (MIA) of This Disease

References

• [1] ClinicalTrials.gov (NCT01644643) Ceftazidime-Avibactam for the Treatment of Infections Due to Ceftazidime Resistant Pathogens. U.S. National Institutes of Health.
• [2] ClinicalTrials.gov (NCT01389700) Pharmacokinetics, Pharmacodynamics and Safety Evaluation of SAR279356 in Intensive Care Unit Mechanically Ventilated Patients. U.S. National Institutes of Health.